Austria vs Switzerland: The number of people with susceptibility test result for rifampicin
Austria
86.84
in 2021
Switzerland
87.3
in 2021
Austria rank
80th
Switzerland rank
79th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Switzerland
How they compare
Switzerland currently reports 87.3 against 86.84 in Austria, a difference of 0.46.
Across all 5 years both countries report, Switzerland has been ahead every year.
Austria ranks 80th and Switzerland ranks 79th of 146 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Austria | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.78 | 92.97 | 4.19 | Switzerland |
| 2020s | 86.89 | 88.89 | 2 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Switzerland?
- Switzerland, at 87.3 against 86.84 in Austria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Switzerland?
- 0.46, with Switzerland ahead.
- How many years of comparable data are there for Austria and Switzerland?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Switzerland rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 80th and Switzerland ranks 79th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.